ArticleBioengineering (Basel, Switzerland)2026
DTARNU-Net: Dense Tiered Attention Residual Nested U-Net for CT Liver Tumor Segmentation.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liver tumor segmentation is a significant task in clinical imaging that involves detecting liver tumors and distinguishing them from the surrounding liver tissue in CT scans. Precision segmentation performs important roles in the initial detection of liver cancer, treatment planning, and monitoring disease development, which also supports doctors, facilitating surgeries and radiation therapy more efficiently. Meanwhile, clinical imaging and segmentation algorithms have been enhanced over the years. The currently prevailing state-of-the-art methods still face multiple difficulties, though, in obtaining precision and reliability in their outcomes. Tumors with irregular shapes, variable sizes, and densities similar to those of surrounding tissues often lead to segmentation inaccuracies and potential misdiagnoses. In this work, we tackle these challenges by developing an advanced process for precise liver tumor segmentation by utilizing CT images from the LiTS dataset. The proposed DTARNU-Net was developed, trained, validated, and evaluated exclusively using the Liver Tumor Segmentation (LiTS) benchmark dataset. No experiments were conducted on the 3D-IRCADbI dataset in this study. All quantitative and qualitative results presented in the manuscript correspond to the LiTS dataset. The LiTS dataset contains contrast-enhanced abdominal CT scans with expert-annotated liver and tumor masks. The proposed model was evaluated using patient-level training, validation, and testing partitions (9:2:2 ratio), and all experiments were independently repeated five times. Statistical significance was assessed using paired Student's t-test (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.